Abbott and the Abbott Fund donate $1 million in funding and products to support Hurricane Sandy relief efforts
2 November 2012 | By Abbott
Abbott and its foundation are providing $1 million in funding and product donations...
List view / Grid view
2 November 2012 | By Abbott
Abbott and its foundation are providing $1 million in funding and product donations...
2 November 2012 | By GlaxoSmithKline
Anthrax has been identified as a serious potential threat...
1 November 2012 | By Bristol-Myers Squibb Company
Portola Pharmaceuticals, Inc., Bristol-Myers Squibb Company and Pfizer announced a clinical collaboration agreement...
1 November 2012 | By Edelman
NEJM published results...
1 November 2012 | By BIS Press Office
New science investment will make sure UK competes and thrives in global race...
1 November 2012 | By Bristol-Myers Squibb Company
NICE has decided to recommend YERVOY®...
31 October 2012 | By GlaxoSmithKline
“GSK fully supports the commitment made by BMJ to drive greater transparency of clinical trial data..."
31 October 2012 | By Boehringer Ingelheim
Results from RELY-ABLE®...
31 October 2012 | By Novo Nordisk
Sales grew 18% driven by Victoza®, NovoRapid® and Levemir®...
31 October 2012 | By Roche
The EC has approved Avastin...
31 October 2012 | By Novartis
Novartis announced the construction of a new state-of-the-art biotechnology production site...
31 October 2012 | By Boehringer Ingelheim
Patients and physicians may have several innovative respiratory treatments available in the coming years...
31 October 2012 | By AstraZeneca
Funding for 15 research projects...
31 October 2012 | By
Significant effects of LEMTRADA™ vs. Rebif ® described in CARE-MS I and CARE-MS II publications...
31 October 2012 | By Gilead Sciences
Data support tenofovir alafenamide fumarate as component of future single tablet HIV regimens...